Original Research
Published on 25 May 2021
A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.664421
- 9,294 views
- 42 citations


